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Abstract
Background: Although resuscitative endovascular balloon occlusion of the aorta (REBOA) in various clinical settings
was found to successfully elevate central blood pressure in hemorrhagic shock, this intervention is associated
with high mortality and may represent a last-ditch option for trauma patients. We conducted a retrospective
study of patients with nonvariceal upper gastrointestinal bleeding (UGIB) who underwent REBOA to identify the
effectiveness of REBOA and reviewed published literatures.
Methods: REBOA were performed by trained acute care physicians in the emergency room and intensive care unit.
The deployment of balloon catheters was positioned using ultrasonography guidance. Collected data included
clinical characteristics, hemorrhagic severity, blood cultures, metabolic values, blood transfusions, REBOA-related
complications and mortality. A literature search using PUBMED to include “aortic occlusion” and “gastrointestinal
bleeding” was conducted.
Results: REBOA was attempted in eight patients among 140 patients with UGIB and median age was 66 years.
Systolic blood pressure significantly increased after REBOA (66 ± 20 vs. 117 ± 45 mmHg, p < 0.01) and the total
occlusion time of REBOA was 80 ± 48 min. Strong positive correlations were found between total occlusion time
of REBOA and lactate concentration (Spearman’s r=0.77), clinical Rockwall score (Spearman’s r=0.80), and age
(Spearman’s r=0.88), respectively.
Conclusion: REBOA can be performed with a high degree of technical success and is effective at improving
hemodynamic in patients with UGIB. Correlations between total occlusion time and high lactate levels, clinical
Rockall score, and age may be important for successful use of REBOA.
Background
Uncontrollable hemorrhage is a main cause of death in
patients with hemorrhagic shock admitted to the emer-
gency department (ED) or intensive care unit (ICU), and
trauma and nonvariceal upper gastrointestinal bleeding
(UGIB) are the most common causes of massive
hemorrhage in acute care setting [1, 2]. Although main
aim of resuscitation is to stop the source of hemorrhage
and restore hemodynamics, persistent hemorrhage can
be rapidly fatal. The options for impending cardiac col-
lapse are resuscitative thoracotomy and aortic clamping
immediately performed in such cases [3].
A recent systematic review of REBOA in various clin-
ical settings was found to successfully elevate central
blood pressure in hemorrhagic shock [4]. Although,
REBOA is increasingly used as an alternative to resusci-
tative thoracotomy, a recent report suggested that
REBOA was associated with increased mortality and
may represent a last-ditch option for trauma patients
with hemodynamic instability in Japan [5]. However,
there are no satisfactory reports regarding the effective-
ness of REBOA among patients with UGIB. Therefore,
we conducted a retrospective study of patients with
UGIB who underwent REBOA at a single emergency
center to evaluate the effectiveness of REBOA. In
addition, we reviewed the published literature to provide
a summary of the experience data.
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The ethics committee of Tokyo Medical University Hachi-
oji Medical Center approved the design of this retrospect-
ive study. UGIB patients with suspected hemorrhagic
shock who subsequently underwent REBOA in the ER or
who were admitted to our intensive care unit (ICU) and
subsequently developed hemorrhagic shock and under-
went REBOA in the ICU were enrolled in this study be-
tween September 2011 and April 2015. Patients with a
systolic blood pressure (SBP) <90 mmHg or a shock index
(SI; ratio of heart rate to SBP) ≥1.0 were considered to be
in shock. We excluded patients aged <15 years and those
who had cardiac arrest on admission or were diagnosed
with any terminal disease during the study period.
Intervention
Patients with hemorrhagic shock in the transient- and non-
response groups were considered to be hemodynamically
unstable on the basis of their response to an initial fluid
resuscitation with 1 L of Ringer’s lactate. Although it is im-
portant to administer blood and blood products as soon as
possible for trauma or non-trauma shock patients, the
preparation of blood or blood products takes time in Japan,
at least in our hospital. Consequently, the empirical transfu-
sion of blood and blood products was initiated as soon as
possible. REBOA was initiated by one or two acute care
physicians in patients showing hemodynamic instability
and an inability to remain normotensive following resusci-
tation. In our department, one acute care physician (TJ)
was trained for ≥1 year as a member of the endovascular
team in the Radiology Department of another university
hospital, whereas all other acute care physicians in our ER
performed REBOA under the guidance of TJ.
For the REBOA procedure, a 10 Fr. Intra-aortic balloon
occlusion (IABO) catheters (BLOCK BALLOON™; Senko
Medical Instrument, Tokyo, Japan) or 7 Fr. IABO catheters
(RESCUE BALLOON®; Tokai Medical Products, Tokyo,
Japan) have been available in our ER and ICU. These are a
double lumen balloon catheter with a stainless steel styled.
For percutaneous deployment of IABO catheters, all ne-
cessary guidewires, sharps and introducers are packaged
together in the kit. An acute care physician first inserts 7
Fr. or 10 Fr. sheath into the femoral artery using the Sel-
dinger method. After insertion of the femoral artery
sheath, the IABO catheter was placed into the aorta and
REBOA was performed. IABO catheter was placed into
the aorta, with selection of the aortic zone for occlusion
according to the recommendations of Stannard et al.
under ultrasonography guidance [6]. Placement of the
balloon is normally performed in Zone I (proximal of the
aorta, origin of the left subclavian artery to the celiac
artery) in patients with suspected UGIB. IABO catheter
positioning was performed under ultrasonography guid-
ance before REBOA placement and confirmed by portable
chest radiography in ER (Fig. 1) [7].
Data collection
The following characteristics were noted from the charts
and radiographs of the patients with hemodynamic
instability: age, sex, vital signs, Acute Physiology and
Chronic Health Evaluation (APACHE) II score,
hemorrhagic severity, blood cultures, metabolic and
coagulation values [pH, lactate concentration, base
excess (BE), prothrombin time, and activated partial
thrombin time], blood transfusion, REBOA-related
complications and mortality. Hemorrhagic severity
was evaluated using SI and severity of UGIB was
evaluated at the onset using the Glasgow-Blatchford
bleeding score (GBS), clinical Rockall score (CRS) and
AIMS65 score [8]. In patients admitted to ER or ICU,
blood cultures and metabolic and coagulation values were
measured at the beginning of resuscitative interventions.
Markers of end-organ dysfunction included serum
aspartate transaminase (AST), blood urea nitrogen (BUN),
creatinine, potassium, sodium, total bilirubin, lactate de-
hydrogenase (LDH), and creatine kinase (CK) as described
in previous reports thoroughly reviewed by two acute care
Fig. 1 Placement of the balloon is performed in Zone I (Patient 5). The tip of IABO catheter (arrow)
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Table 1 Clinical characteristics of the patients
Variables Patient 1 Patient 2 Patient 3 Patient 4 Patient 5 Patient 6 Patient 7 Patient 8
Age (y) 69 36 83 64 78 69 50 79
Sex male male male male male male male male
Body temperature (°C) 35.5 36.2 36.8 37.3 36.0 37.0 36.1 35.7
Hemodynamics
Shock index 2.3 0.8 2.1 2 0.8 1.7 1.1 1.3
SBP pre-REBOA (mmHg) 60 90 96 54 41 63 61 –
SBP post REBOA (mmHg) 97 111 206 74 82 112 140 –
ΔSBP (mmHg) 37 21 110 20 41 49 79 –
APACHE II 22 7 26 31 22 26 21 30
Severity of upper gastrointestinal bleeding
Glasgow Blatchford bleeding score 17 7 19 11 14 13 12 17
Clinical Rockall score 3 3 4 3 5 3 2 3
AIM 65 score 3 0 4 3 2 5 0 2
Initial blood values
White blood cell count (/μL) 12900 13600 24000 17300 9120 10600 11500 7170
Hemoglobin (g/dL) 5.5 14.8 11.2 7.3 5 5.3 8.8 6.1
Hematocrit (%) 16 44 31 21 15 16 26 19
Platelet connt (×104/μL) 11.9 34.6 9.3 36.8 17.3 12.2 36 22.9
BUN (mg/dL) 18.7 21.1 62.1 8.2 44.1 13.9 46.9 32.0
Lactate (mmol/L) 11.1 1.3 9.6 5.6 15.8 6.6 63 15.0
pH 7.25 7.36 7.38 6.94 7.35 7.24 7.30 6.96
Base excess (mmol/L) 0.1 –2.5 −11.5 −14.5 −14.6 –9.3 –9.4 –21.8
Prothrombin time (%) 51 113 64 62 83 51 105 62
APTT (sec) 64.5 30.1 35.3 240 64.3 123.9 33.4 –
Diagnosis Gastric ulcer Gastric ulcer Duodenum ulcer Anastomotic bleeding Duodenum ulcer Left gastric artery aneurysm Duodenum ulcer Esophageal cancer
Definitive hemostatic control endoscopy endoscopy endoscopy AE AE (failed endoscopy) AE (failed endoscopy) AE (failed endoscopy) AE














Table 1 Clinical characteristics of the patients (Continued)
Blood and blood product transfusion within 24 h (mL)
PRBC 1400 280 1960 2520 1960 2800 3080 1680
FFP 1200 0 1200 1680 2160 1920 1920 720
Re-bleeding no no no no yes yes no no
REBOA
Total occlusion time (min) 57 20 140 54 145 95 50 Failure
REBOA-related complication none none none none none none none none
Outcome within 30 days Alive Alive Alive Alive Died < 24 h Alive Alive Died < 24 h
SBP systolic blood pressure, REBOA resuscitative endovascular balloon occlusion of the aorta, APACHE acute physiology and chronic health evaluation, BUN blood urea nitrogen. APTT activated partial thrombin time, AE














physicians (SH and TJ) [9, 10]. These values were measured
within 12 h after definitive hemostasis. The REBOA-related
complications included vessel injuries (i.e., aortic dissection,
rupture, perforation, pseudo-aneurysm, and arteriovenous
fistula), groin hematoma, embolization, air emboli, periph-
eral ischemia, and organ dysfunction.
Literature search
A literature search using PUBMED to include “aortic oc-
clusion” and “gastrointestinal bleeding” was conducted.
Original articles and case reports published in English
language were reviewed, and follow-up references listed
were further investigated.
Statistical analyses
Data from all eligible patients were analyzed. Continuous
variables are shown as mean values with standard
deviation in text and median and interquartile range in
Tables. Between-group differences were statistically
assessed using the Mann–Whitney U test for continuous
variables, paired t test for continuous dependent variables
and the Fisher’s exact test for categorical variables. The
Spearman correlation coefficient was used to identify cor-
relations between the evaluated parameters. All statistical
analyses were performed using Prism version 6.0a statis-
tical software (GraphPad Software, San Diego, CA, USA).
Categorical variables were calculated as the ratio (percent-
age) of the frequency of occurrence. A probability (p)
value of > 0.05 was considered statistically significant.
Results
Demographics and clinical characteristics
REBOA was attempted in eight patients among 140 pa-
tients with UGIB. The mean age was 66 ± 16 years, and
all of the patients were male. The mean SI, GBS, CRS,
AIMS65 score and APACHE II were 1.5 ± 0.6, 16 ± 4, 3 ±
1, 2 ± 2, and 23 ± 7, respectively. The demographics and
clinical characteristics of all patients are shown in Table 1.
Placement of the IABO catheter failed in one patient aged
79 years with severe aortic calcifications. Definitive
hemostasis was endoscopy in 3 cases, anigo-embolization
(AE) in 2 cases, and AE after failed endoscopy in 3 cases,
respectively. The total occlusion time of REBOA was 80 ±
48 min in this study. The mean volume of packed red
blood cells, fresh frozen plasma and Ringer’s lactate ad-
ministered during the resuscitation were 2000 ± 949 mL,
1440 ± 733 mL, and 4000 ± 2363 mL, respectively. The
mortality rates within 24 h and 30 days were 15 % each.
No REBOA-related complications were encountered.
Changes in acute care management with REBOA
Systolic blood pressure was significantly higher after ini-
tiating of REBOA (66 ± 20 vs. 117 ± 45 mmHg, p < 0.01).
Heart rate, lactate concentration, and BE were not
significantly different between before and after REBOA.
Initial serum concentration of AST, BUN, creatinine,
CK, potassium, sodium, total bilirubin, white blood cell
counts, and C-reactive response were not significantly
different compared with those after completion of
hemostasis. The serum concentration of LDH following
REBOA was significantly higher than that before REBOA
(227 ± 154 vs. 595 ± 406 IU/L, p=0.04) (Table 2).
Correlations between total occlusion time and vital
indicators
Strong positive correlations were found between total
occlusion time and lactate concentration (Spearman’s
r=0.77, p=0.04), CRS (Spearman’s r=0.80, p=0.03), and
age (Spearman’s r=0.88, p < 0.01), respectively (Fig. 2).
Discussion
REBOA is an adjunct procedure designed to sustain the
circulation until definitive hemostasis is obtained.
Upon review of the existing literature, it was evident
that there are only a very limited number of publications
related to REBOA treatment for UGIB, and only four case
references were retrieved. We identified 4 published re-
ports involving 4 patients (1 patient per 1 report) with
hemodynamic instability caused by UIGB. Among them, 2
Table 2 Comparison of the vital indicators between before and
after REBOA





61 (57–77) 111 (90–126)*
Heart rate (beat/min) 126 (112–131) 123 (113–127)




Hemoglobin (g/dL) 7.3 (5.4–10) 9.7 (8.7–10.6)
Platelet (×104/μL) 17.3 (12.1–35.3) 10.3 (7.2–13.6)
Prothrombin time (%) 64 (57–94) 56 (50–70)
Lactate (mmol/L) 3.2 (2.9–6.0) 5.4 (4.3–7.0)
Base excess (mmol/L) −11.5 (−14.6 - –8.7) −3.1 (−4.8 - –1.4)
Blood urea nitrogen (mg/dL) 21.1 (16.3–45.5) 30.8 (16.6–38.8)
Creatinine (mg/dL) 0.97 (0.90–1.03) 1.14 (0.83–1.29)
Aspartate transaminase (U/L) 14 (11.5–43.5) 101 (64.5–608)
Total bilirubin (mg/dL) 0.40 (0.35–0.6) 0.60 (0.45–0.80)
Potassium (mmol/L) 4.0 (3.8–4.1) 3.5 (3.5–4.2)
Sodium (mmol/L) 138 (135–139) 137 (136–141)
Creatine kinase (U/L) 56 (47–80) 263 (109–620)
Alkaline phosphatase (U/L) 191 (153–197) 137 (104–249)
Lactate dehydrogenase (U/L) 158 (123–285) 411 (328–862)*
C reactive protein (mg/dL) 1.61 (0.55–2.64) 1.07 (0.70–3.55)
IQR interquartile range, REBOA, resuscitative endovascular balloon occlusion of
the aorta; * = p < 0.05 vs. Before REBOA
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patients underwent REBOA for duodenum ulcers, one
child for aorta-esophageal fistula, and one for unknown
UGIB [11–14]. Table 3 showed the clinical characteristics.
Placement of the balloon was in Zone I without fluoros-
copy and hemodynamics have improved in all cases. There
was no REBOA-related complication and the mortality
rate was 25 %. To the best of our knowledge, the present
study represents the first retrospective study to evaluate
the utility of REBOA among patients with UGBI.
In the present study, our trained acute care physicians
could achieve REBOA procedures in the ED/ICU with a
high degree of technical success. Blood pressure following
REBOA did significantly increased compared with that be-
fore REBOA, and no significant differences detected be-
tween patients with UGIB in terms of almost all markers of
end-organ dysfunction. A recent study reported a REBOA
duration of >90 min in an animal model of hemorrhage-
induced organ dysfunction, particularly that of the kidneys
and liver. Our results were consistent with those reported
by Markov et al. [9]. We also found clinically significant
correlations between the total occlusion time of REBOA
and lactate concentration and CRS measured at the begin-
ning of resuscitation among patients with UGIB. Conven-
tionally, these parameters are used to confirm a suspected
massive hemorrhage and permit the earlier achievement
of hemostasis or administration of massive transfusion if
required [15]. Thus, it is very important to shorten the
time from ED arrival to initiation of hemostatic proce-
dures before hemodynamic collapse as much as possible.
Although endoscopic treatment for UGIB is generally ac-
ceptable, it can be difficult to achieve complete hemostasis
in some patients with a high lactate concentration and/or
CRS. Excessive hemorrhage may rapidly become fatal and
can be challenging to secure. In addition, it makes main-
taining a visual field during endoscopy difficult. These
complications result in significant time delays during pro-
cedures. In the present study, one patient (Patient No. 2)
who had a transient response to initial resuscitation had
his systolic blood pressure decrease to 80 mmHg. It was
then decided to place an IABO catheter prior to endo-
scopic treatment, and an IABO catheter was promptly
inserted at ED. His blood pressure subsequently increased
Fig. 2 Significantly positive correlation between the total occlusion time of the intra-aortic balloon occlusion catheter and lactate concentration, clinical
Rockall score and age. (a) Lactate concentration, Spearman’s r=0.77; (b) clinical Rockall score, Spearman’s r=0.80; and (c) age, Spearman’s r=0.88
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following balloon inflation, and he underwent endoscopic
treatment at ED. The bleeding vessel was visualized from
the ulcer at the gastric angle, and the bleeding was
arrested using balloon inflation. We believe that this case
denotes the effectiveness of a balloon-assisted hemostatic
technique in decreasing bleeding to secure a visual field
and to reduce the volume of blood transfusion.
The immediately availability of an IABO catheter and
the earlier introduction of REBOA have enabled us to
sustain the circulation as an adjunct procedure until de-
finitive hemostasis is attained. A formal algorithm that is
utilized in a prospective manner is essential for UGIB
treatment (endoscopy, AE, and surgery) and may
shorten the occlusion time of REBOA. In the present
study, one patient (Patient No. 5) with failed endoscopic
hemostasis died within 24 h; the total occlusion time
was 145 min. Although, REBOA for 60 min was report-
edly to be well tolerated in an animal model of uncon-
trolled hemorrhagic shock, a recent report has suggested
that partial REBOA could increase the survival time to
180 min while maintaining central blood pressure and
carotid blood flow [10, 16]. In future, this method may
be helpful for successful use of REBOA in patients with
a high lactate concentration and a high CRS.
The major complications observed with REBOA in-
cluded vessel injuries (i.e. aortic dissection, rapture and
perforation), embolization, and peripheral ischemia. Re-
cent reports have reported no vessel injuries caused by
an IABO catheter or inflated balloon in trauma patients
[17]. We routinely use ultrasonography to guide posi-
tioning of the IABO catheter during procedures and
evaluate balloon placement using portable radiography
after catheter deployment and there was no REBOA-
related complications. Giuliani et al. support this result
in the study showing that ultrasonography alone is safe
and accurate as fluoroscopy for positioning and deploy-
ment of an IABO catheter [7].
However, this study has several limitations, particularly
the small number of evaluated patients. Second, this was
not a randomized, controlled trial because in the acute care
setting, it is difficult to perform a randomized trial in a sin-
gle emergency center. Furthermore, use of a propensity
score is not suitable for a small sample size. Thus, large
multi-institutional studies are essential for further evaluat-
ing the utility of REBOA against UGIB. Third, patients
were allocated to REBOA use and treatments according to
the decision of the attending lead acute care physicians,
and this should be considered when interpreting our out-
comes. Although patient selection was carefully performed,
we believe the number of patients could have been greater.
Consequently, our methods may be evaluated and incorpo-
rated into future studies to optimize the criteria for patient
selection. Finally, application of this approach in other
emergency centers may be limited by a lack of resources.
Conclusion
Immediate availability of an IABO catheter device can
perform REBOA in ER and ICU and achieve a high de-
gree of technical success. Temporary aortic balloon oc-
clusion is effective at improving hemodynamics and
perfusion in patients with UGIB. Furthermore, the cor-
relations of total occlusion time and high clinical Rockall
score, as the most relevant one, lactate levels, and ad-
vanced age may be important for successful use of
REBOA. Formal prospective study is warranted to clarify
the role of this adjunct procedure in UGIB treatment.
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